Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...

Metastatic prostate cancer is currently associated with high morbidity and mortality rates. In addition, patients respond very differently to standard treatments such as hormone therapy or radiation ...

A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with higher recurrence risk after breast-conserving surgery. A Radiation ...

Studies published by 20/20 Biolabs and several independent research groups in the U.S. and Asia over the past 10 months add to the growing body of evidence that our company’s patented multi-cancer ...

Many people know that finding cancer early, before it spreads, may help increase the chances of treating and surviving cancer ...

Key Takeaways A highly sensitive DNA test can detect hidden leukemia cells that predict if a patient’s cancer is likely to ...

Prostate cancer is one of the most common cancers affecting men around the world. In many countries, including Germany, it is the most frequently diagnosed cancer in men. Each year, about 65,000 men ...

Diagnosis of stomach cancer (also known as gastric cancer) is now occurring more often at earlier stages, likely related to advances in tests and imaging. Importantly, stomach cancer is also being ...

ctDNA MRD monitoring may augment scans and tumor markers, enabling earlier detection of gastroesophageal cancer recurrence, especially hard-to-image peritoneal relapse.

Multicancer assays leverage cfDNA methylation patterns to detect malignancy and infer tumor origin, with reported tissue-of-origin prediction approaching 87% accuracy in real-world experience. The 142 ...

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...